Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 24 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 8343549

    Therapeutic uses of Dunaliella powder

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  2. US 8337813

    Contrast agents

    Northwestern University · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  3. US 8338624

    Isoflavone derivatives and uses thereof

    Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  4. US 8334409

    Process for purifying rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  5. US 8333959

    Ex-vivo application of solid microparticulate therapeutic agents

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  6. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  7. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  8. US 8288530

    Method of preparing macromolecular contrast agents and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  9. US 8268849

    Multifunctional Antioxidants and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  10. US 8257915

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  11. US 8247410

    Pyrimidine substituted purine derivatives

    VERASTEM, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  12. US 8247563

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  13. US 8242076

    Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  14. US 8236835

    Heterocyclic inhibitors of stearoyl-CoA desaturase

    Xenon Pharmaceuticals Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  15. US 8222392

    Kit for detection of telomerase reverse transcriptase nucleic acids

    The Regents of the University of Colorado · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  16. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  17. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  18. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  19. US 8193309

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  20. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  21. US 8188055

    Inactivators of O6-alkylguanine-DNA alkyltransferase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2012 · Expires May 24, 2032

    granted

  22. US 8188095

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted

  23. US 8182807

    Method for inhibiting reperfusion injury in the brain

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted May 22, 2012 · Expires May 17, 2032

    granted

  24. US 8168222

    Amphiphilic polymer-protein conjugates and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.